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Cryopreservation of red blood cell units with 
a modified method of glycerolization and 
deglycerolization with the ACP 215 device 
complies with American and European 
requirements
J. List, M. Horvath, G. Weigel, and G.C. Leitner
RepoRt
Current red blood cell (RBC) glycerolization with the ACP 
215 device is followed by volume reduction of the glycerolized 
RBCs before freezing. We investigated a modified method of 
glycerolization and deglycerolization which eliminates the final 
centrifugation step that reduces glycerolized RBC supernatant. 
A total of 37 RBC units collected from healthy volunteers 
were analyzed. After removal of the supernatant, RBCs were 
glycerolized using the high glycerol method and stored at –80°C. 
After deglycerolization, RBCs were preserved with either SAG-M 
or AS3 and stored for at least 10 or 14 days, respectively. Quality 
of stored RBCs was assessed by measuring osmolarity, blood 
cell counts, free hemoglobin, adenosine triphosphate (ATP), 
hemolysis, and glucose. The overall RBC mass recovery after 
deglycerolization was 86 ± 7.6 percent, and the osmolarity was 336 
± 23 mOsml/kg H2O. The hemolysis for stored components at the 
end of their shelf life was 0.21 ± 0.08 percent for AS3-preserved 
RBCs and 0.25 ± 0.08 percent for RBCs preserved with SAG-M. 
On expiration, 32 percent of initial ATP values were measured in 
AS3-preserved RBCs vs. 62 percent in SAG-M–preserved RBCs. 
This modified method of glycerolization and deglycerolization 
meets the quality requirements of the European Council and the 
AABB standards. The prolonged storage of thawed RBCs enables 
optimized transfusion management for patients with rare blood 
groups. Immunohematology 2012;28:67–73.
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Cryopreservation of red blood cells (RBCs) still remains 
an important method for maintaining an inventory of rare 
RBC units and managing special transfusion circumstances. 
The influence of RBC distress on the quality of RBCs during 
the collection process and the extent of storage lesions during 
liquid storage (4°C ± 2°C) is well known.1,2 It has been shown 
previously that the length of centrifugation and especially the 
gravitational force play an important role in the impairment 
of RBCs.1 High gravitational forces or a long exposure time 
results in accelerated intracellular ATP degradation and 
consumption of glucose during storage as a result of increased 
membrane repair processes. Subzero storage of RBC units 
reduces erythrocyte metabolism and allows a frozen storage 
period of at least 10 years.3 However, RBC damage during the 
collection procedure may affect the quality of deglycerolized 
RBC units during postthaw storage. A variety of freeze and 
thaw protocols have evolved so far. The methods differ with 
regard to cryoprotectants, storage temperature, and thawing 
and washing procedures.4 In Europe, predominantly the high-
glycerol method (HGM) is used because of the ease of storage 
in a –80°C freezer without the need for highly technical 
equipment. The low-glycerol method (LGM) requires a storage 
temperature of –190°C, which can only be achieved in liquid 
nitrogen. Currently, RBC units that undergo the HGM are 
centrifuged at least three times: during the collection process, 
before glycerolization to achieve a hematocrit (Hct) of at least 
75 percent, and before freezing to remove the supernatant 
glycerol.5 In this prospective study we investigated a modified 
freeze and thaw protocol by eliminating the last centrifugation 
step in conventionally collected and apheresis-derived RBC 
units. The quality of RBCs after thawing was assessed by 
analyzing osmolarity, recovery of RBC mass and hemoglobin 




The aim of this study was to evaluate a modified method 
of glycerolization and deglycerolization of RBC units with the 
automated device ACP 215 (Haemonetics Corp, Braintree, 
MA), which eliminates the highly manual step of supernatant 
reduction before freezing. This change in manipulation is 
compensated by a modification in the deglycerolization 
process as shown in Table 1. The dilution volume and the 
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dilution rate are the crucial points. They were calculated by the 
scientific board of Haemonetics. The objective was to reduce 
the osmolality of the glycerolized and frozen components 
to values of conventionally cryopreserved units before 
deglycerolization and to avoid osmotic shock of RBCs during 
the deglycerolization process.
Each manipulation step bears the risk of bacterial 
contamination or artificial damage of the component, 
which may be of particular interest in certain hemoglobin 
abnormalities.6,7 A simplified method reduces the risk of 
component impairment and is also time sparing, which is 
certainly an advantage in daily routine. Second, glycerolized 
RBCs have a large volume that is difficult to handle in routine 
blood banks as the centrifuge buckets are normally not 
designed for such high volumes.
To evaluate the applicability of this simplified method 
to different production methods, conventionally collected as 
well as apheresis-derived RBCs were investigated. A major 
requirement for managing stockpiling of cryopreserved RBC 
units is the shelf life after deglycerolization. We included 
two preservation solutions (SAG-M, AS3) in our postthaw 
investigation to compare their suitability. In consideration of 
previous studies, which showed hemolysis above the threshold 
of 0.8 percent in SAG-M–preserved deglycerolized units 
within 1 week, the postthaw shelf life was set at 10 days for 
SAG-M units vs. 14 days for AS3 units.8,9
Finally, we assessed the compliance of these modified 
RBC units with requirements for cryopreserved RBC 
concentrates, as defined by the Council of Europe (CE) and the 
AABB standards.3,10 In brief, hemolysis should stay less than 
0.8 percent at the end of shelf life, and the minimal required 
content of hemoglobin (Hb) is 36 g/unit.10
Donors
RBCs were collected from routine donors of the Austrian 
Red Cross Blood Service by standard whole blood (WB) collec-
tion (n = 17), and from volunteer donors of the Department 
of Blood Group Serology and Transfusion Medicine (Medical 
University of Vienna) who qualified for multicomponent 
collection (MCC). RBC double units were collected by two 
automated collection devices (MCS+, Haemonetics, n = 6) 
and (Cymbal, Haemonetics, n = 4) according to the technical 
manual. The study was approved by the local ethics committee, 
and the donors gave written informed consent.
Red Blood Cell Units
All RBCs (WB collections and apheresis-derived) were 
leukocyte-depleted, suspended in SAG-M, and stored for 6 
days at 4°C ± 2°C before freezing. A prerequisite for further 
manipulation was the compliance of the RBC units with the 
requirements of the EC concerning Hb content/unit (40 g/
unit) and leukocyte contamination (≤1 × 106/unit).11 RBC 
units were connected to 500-mL transfer bags by a sterile 
connecting device (SCD, Haemonetics) and centrifuged for 
15 minutes at 2000 rpm (2858g) in a floor model, cooling 
centrifuge (Roto Silenta RP, Hettich, Vienna, Austria). 
Using a plasma extractor, supernatant was extracted to the 
transfer bag to achieve a Hct of at least 75 percent.5 Finally, 
after drawing blood samples to determine the actual Hct, the 
remaining packed RBC units were connected to the 1800-mL 
freezing bag (EVA bag reference GSR 8000AU Macopharma, 
Werken, Belgium) using a sterile connecting device. RBC units 
were defined as small (RBC mass ≤130 g), typical (RBC mass 
>130 g and ≤180 g), or large (RBC mass >180 g).
Freezing Procedure
To achieve the final concentration of 40 volume-percent 
glycerol, the amount of added 57 gram-percent glycerol solution 
was calculated depending on the actual hematocrit of the units. 
The RBC units were glycerolized with the ACP 215 using the 
HGM (Haemonetics) according to protocol. RBC units and the 
glycerol solution were at room temperature. Calculation of the 
amount of added glycerol was done automatically by the device 
and was completed within 10 minutes. Finally, glycerolized 
RBC units were frozen by placing them into a –80°C freezer 
(Revco Freezer, Thermo Scientific, Langenselbold, Germany) 
and stored for at least 10 to 14 days. Glycerolized RBCs had a 
mean volume of 578 mL (standard deviation, 89 mL; range, 
354 to 736 mL).
Thawing Procedure
After 10 days (SAG-M) and 14 days (AS3), frozen 
RBCs were thawed with a a 37°C pulsed-air chamber with 
infrared temperature control of RBC bag content (Sahara 
Thawer, Transmed Medizintechnik Gmbh, Bad Wünnenberg, 
Germany). The thawing procedure was completed when a 
Table 1. Comparison of variables using the current and postthaw 
modified ACP 215 washing procedures
Current ACP 215 
configuration
Study ACP 215 
configuration*
Hypertonic solution volume (mL) 50 50
Hypertonic solution flow rate (mL/min) 150 150
Saline dilution volume no. 1 (mL) 340 600
Saline dilution flow rate (mL/min) 60 110
*Modified washing volumes
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temperature of 34°C was reached. Deglycerolization was 
performed with the ACP 215 according to the manufacturer’s 
protocol, using either the regular bowl set (LN235) for small 
and typical units (130–180 g of RBC mass) or the large 
bowl set (LN236) for large units with more than 180 g of 
RBC mass. The deglycerolization process included an initial 
deglycerolization step with hypertonic saline solution (12%) to 
facilitate the intracellular glycerol removal and five consecutive 
washing steps with a saline rinse solution (0.9% saline, 0.2% 
glucose-buffered solution bags, BIO-Wash, Haemonetics) 
to achieve a remaining glycerol content of less than 1 gram-
percent. For this purpose we compared the color of the final 
wash fluid with the blocks of a color comparator (Hemolysis 
Color chart, Haemonetics) and measured the osmolarity of 
the component, as recommended by the AABB.3,12 The entire 
deglycerolization process lasted an average of 69 minutes 
(standard deviation ± 4.5 min). The main difference between 
the standard and modified deglycerolization methods is shown 
in Table 1. Postdeglycerolization RBC units were resuspended 
either in SAG-M (Cymbal, n = 4; MCS, n = 6; WB, n = 8) or in 
AS3 (Cymbal, n = 4; MCS, n = 6; WB, n = 9) and stored at 4°C 
(± 2°C) for another 10 (SAG-M) or 14 (AS3) days.
Assessment of In Vitro Quality
Our aim was to assure that the RBC units treated with the 
new, modified method of glycerolization, freezing, and deglyc-
erolization still met the required standards of the CE and the 
AABB.3,10,12 Storage lesion was assessed by measuring volume 
(net weight), blood counts (RBC mass), Hct, Hb, glucose, 
pH, supernatant (free) hemoglobin (fHb), and intracellular 
ATP content. The samples were taken at defined time 
points: after collection, before glycerolization, after thawing, 
after deglycerolization, and during storage. Additionally, 
supernatant osmolarity was measured after deglycerolization. 
All samples were drawn under aseptic conditions on days 0 
(day of deglycerolization), 3, 5, 7, and 10 (SAG-M), and on days 
0, 5, 7, 10, and 14 (AS3) of storage.
Laboratory Analyses
The weight was measured by an electronic scale and 
calculated by the net weight of the component divided by 
weight density of the RBCs. The concentration of Hb in the RBC 
supernatant was analyzed (AU 5430, Olympus Diagnostika, 
County Clare, Ireland) by the photometric color method. The 
blood count was measured using an automated cell counter 
(Cell Dyn 3500CS, Abbott Diagnostics, South Pasadena, CA). 
Osmolarity of the RBC units was determined (OSMO AKRAY 
OM-6050, A. Menari Diagnostics, Florence, Italy). Glucose was 
measured (Olympus AU 5430, Olympus Diagnostika) with the 
enzymatic, hexokinase method. ATP was measured by high-
performance liquid chromatography as described previously,13 
and pH was analyzed at 37°C (ABL 80, Radiometer Gmbh, 
Brønshøj, Denmark). All analyses were done according to the 
manufacturer’s instructions. Hemolysis (%) was calculated as 
follows: ([fHb × {100–Hct}]/Hbtotal)/1000.
Statistical Analyses
Results were expressed as mean and standard 
deviation for descriptive purposes in the text. Because of the 
nonnormal distribution of data all comparisons were made 
by nonparametric statistics. Procedures were split into four 
subgroups by the nature of the blood collection method (WB or 
apheresis) and of the preservation solution used to resuspend 
deglycerolized RBCs (SAG-M or AS3). Asigned-rank test was 
done with Minitab (Wilcoxin, Minitab®15.1.0.0, Inc., State 
College, PA). Comparisons between the various collection 
methods within a group were done using the Kruskal-Wallis 
test. A probability value of less than 0.05 was considered 
significant.
Results
Red Blood Cell Collections
All collected RBC units (17 WB collections, 6 MCS+–
derived double units [12 single RBC units], and 4 Cymbal-
derived double units [8 single RBC units]) met the requirements 
of the CE and were included in the study.11 No significant 
differences were found in component characteristics among 
the different collection methods. Values are detailed in Table 2. 
Thirty-three RBC units were defined as typical (130 g < RBC 
mass < 180 g), and four were defined as large (RBC mass > 
180 g).
Red Blood Cells Deglycerolized
The volume of all deglycerolized RBC units was 305 ± 13 
mL and ranged from 277 to 357 mL. The RBC mass in all units 
was greater than 140 mL, and Hb content/unit was greater 
than 36 g (Table 3). The overall Hb recovery in the 37 tested 
RBC units after deglycerolization was 75 ± 6.5 percent, and 
the overall RBC mass recovery was 86 ± 7.6 percent. Recovery 
of Hb and RBC mass was significantly lower in MCS+ and 
Cymbal than in WB-derived components. We measured a 
recovery of 72 percent Hb and 85 percent RBC mass for MCS+ 
and Cymbal components vs. 78 percent Hb and 90 percent 
RBC mass for WB-derived components (p < 0.05 for Hb), 
respectively. The overall osmolarity was 336 ± 23 mOsm/kg 
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H2O after deglycerolization, which was well below the AABB 
requirements of 400 mOsm/kg,8,12 and MCV returned from a 
mean of 134 femtoliters (fL; ± 4.3) during frozen storage to 99 
fL (± 4.3), which represents 108 percent of initial values. The 
color comparator indicated a residual glycerol of less than 1 
percent. Detailed values for both additive solutions are given 
in Table 4.
Red Blood Cells Stored in Either SAG-M or AS3
Hemolysis
The mean overall hemolysis for all stored components was 
0.23 ± 0.08 percent at the end of shelf life, set by the study 
design. It increased during storage as expected, but remained 
less than the threshold of 0.8 percent in all units. Although 
it was slightly higher in SAG-M–preserved units, there was 
no significant difference between the preservation solutions 
(SAG-M, AS3) for Cymbal- and WB-derived RBC units. RBCs 
collected with the MCS+ showed significantly higher hemolysis 
when stored in SAG-M (p < 0.05). The significantly lowest 
hemolysis was measured in WB-derived RBCs irrespective of 
the preservation solution (Fig. 1).
intracellular adenosine tripHospHate content and Glucose
The overall intracellular ATP was 48 ± 19 percent of initial 
values at the end of shelf life, which is considerably greater than 
the threshold of 10 percent residual ATP content.14 During 
storage, ATP values decreased continuously to 32 percent (Day 
14) of initial values for AS3-preserved units and to 62 percent 
(Day 10) for units stored in SAG-M, respectively (p < 0.05; 
Table 4, Fig. 2). On day 10, 40 percent of initial ATP values 
were measured in AS3-preserved units. Initial intracellular 
ATP content was significantly higher in WB collections than in 
apheresis-derived units (Table 2, Fig. 2; p < 0.05). The lowest 
intracellular ATP values and the highest purine degradation 
were measured in AS3-preserved, MCS+–derived RBCs (p 
< 0.05; Fig. 2A). The preservation solution had almost no 
impact on the course of ATP degradation in RBCs produced 
with Cymbal (Fig 2). Consumption of glucose was comparable 
irrespective of the collection method and preservation solution 
(Table 2).
Discussion
In this study we evaluated a modified RBC freeze and 
thaw method that eliminated the third centrifugation step. 
This procedure is not only simpler to perform, but it also may 
reduce RBC lesions by shortening exposure to centrifuge 
force. The impact of shear stress caused by centrifugation is 
Table 2. Manipulation characteristics of RBC units collected with 
MCS+, with Cymbal, or conventionally (whole blood)*
Variable MCS+ (n = 12) Cymbal (n = 8) WB (n = 17)
Volume (mL) 276 ± 20 256 ± 9 292 ± 14
Hct (%) 60 ± 2 63 ± 6 58 ± 5
Hb (g/dL) 19.8 ± 0.7 20.6 ± 2.0 19.3 ± 1.6
ATP (pg 106 erythrocytes) 118 ± 15 101 ± 17 146 ± 16†
Glucose (mg/dL) 457 ± 19 421 ± 18 488 ± 24
Hb/unit (g/unit) 55 ± 6 53 ± 5 56 ± 6
RBC mass (mL) 165 ± 17 161 ± 14 171 ± 19
*Values are expressed as mean ± standard deviation.
†p < 0.05.
ATP = adenosine triphosphate; Hb = hemoglobin; Hct = hematocrit;  
RBC mass = red blood cell volume; WB = whole blood.
Table 3. Component characteristics and recovery of 
deglycerolized RBC units collected with MCS+, with Cymbal,  
or conventionally (whole blood)*
Variable MCS+ (n = 12) Cymbal (n = 8) WB (n = 17)
Recovered Hb content/unit (%) 73.5 ± 3.8 69.0 ± 7.7 78.0 ± 7.2
Hb (g/dL) 12.3 ± 0.6 12.5 ± 0.9 14.1 ± 1.4†
Recovered RBC mass (%) 85.5 ± 4.2 83.0 ± 8.4 90.0 ± 10.2†
Hct (%) 43.6 ± 3.08 45.2 ± 3.1 49.1 ± 5.06†
MCV (fL) 96.5 ± 2.4 102 ± 7.6 98 ± 3.1
Osmolarity (mOsm/kg H2O) 336 ± 25 345 ± 23 332 ± 23
*Values are expressed as mean ± standard deviation.
†p < 0.05.
Hb = hemoglobin; Hct = hematocrit; MCV = mean cell volume;  
RBC = red blood cell; WB = whole blood.
Table 4. Osmolarity after deglycerolization on Day 0 and the 
course of hemolysis and adenosine triphosphate percent in 
SAG-M– and AS3-preserved deglycerolized red blood cells after 
deglycerolization and during storage until end of shelf life*
Day 0
SAG-M (n = 18) 
Osmolarity mOsm/kg H2O 
358 ± 12
AS3 (n = 19) 
Osmolarity mOsm/kg H2O 
316 ± 8
Hemolysis (%) ATP (%) Hemolysis (%) ATP (%)
Day 0 0.14 ± 0.04 100 ± 12 0.14 ± 0.03 93 ± 18
Day 3 0.17 ± 0.06 86 ± 27 — —
Day 5 0.17 ± 0.04 83 ± 15† 0.14 ± 0.03 73 ± 14†
Day 7 0.18 ± 0.05 72 ± 15† 0.16 ± 0.07 59 ± 14†
Day 10 0.25 ± 0.08 62 ± 12† 0.17 ± 0.05 40 ± 12†
Day 14 — — 0.21 ± 0.08 32 ± 10
*Adenosine triphosphate (ATP) results are calculated in percent of the initial 
(preglycerolization) values; for comparison day 10 (expiration for SAG-M–
preserved units) is highlighted.
†Statistical significance between SAG-M and AS3 with p < 0.05.
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well known.1,2,6,15 A major drawback of our study is the lack 
of a conventionally treated control group, but this study was 
conducted to provide evidence that the modified method is an 
alternative for all centers lacking the appropriate equipment, 
as we do. However, the Technical Manual of the AABB and 
the European guidelines provide clear requirements for frozen 
and thawed RBC units. Thus, we verified our results with the 
requirements of the international authorities and compared 
them with previous publications.
To remove glycerol almost completely after thawing, 
the washing procedure was modified (Table 1). The mean 
osmolarity of 336 mOsm/kg H2O (threshold, 400 mOsm/
kg H2O), the mean MCV of 108 percent of initial values, and 
the color comparator (degree of hemolysis) indicated sufficient 
removal of glycerol.8 In accordance with previous observations, 
we also found significantly higher osmolarity in SAG-M–
preserved units than in AS3 RBCs (p < 0.05; Table 4), although 
no differences were seen among the three collection methods 
Fig. 1. Course of hemolysis during 14 days’ postthaw storage for AS3-preserved (A) and SAG-M–preserved (B) components of deglycerolized 
red blood cell units collected with MCS+ (circles, dash-dotted line), with Cymbal (Cym; squares, dotted line), or conventionally (whole blood 
[WB]; triangles, solid line). Values are given in mean and standard deviation on Days 0 (immediately after deglycerolization), 3, 5, 7, and 10 
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Fig. 2. Course of intracellular adenosine triphosphate (ATP) values during 14 days’ postthaw storage for AS3-preserved (A) and SAG-M–
preserved (B) components of deglycerolized red blood cell units collected with MCS+ (circles, dash-dotted line), with Cymbal (Cym; 
squares, dotted line), or conventionally (whole blood [WB]; triangles, solid line). Values are given in mean and standard deviation on Days 
minus (–) 1, which represents the initial value after collection and before glycerolization, on Day 0 (immediately after deglycerolization), on 
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(Table 3). This can be explained by the mannitol and sodium 
content in SAG-M causing higher osmolarity of the solution 
itself.8 Interestingly, the highest recovery of RBC mass (90%) 
and total Hb (78%) after deglycerolization was measured in 
conventionally collected (WB) RBCs. Moreover, during further 
storage the lowest hemolysis was also measured in WB-derived 
RBCs, irrespective of the nature of preservation solution (Fig. 
1). This can be best explained by the high ATP content found 
in WB RBCs before freezing (Table 2). ATP is known to power 
all energy-requiring processes, such as the Na+/K+ pump 
and membrane repair.13,14,16 Thus, RBC membrane stability 
during collection and manipulation could obviously be best 
maintained in WB-derived RBCs, which may have led to less 
ATP degradation than in apheresis-derived components.
The composition of the additive solution also influences 
the extent of hemolysis and degradation of intracellular ATP 
during storage and treatment.16–19 As described previously, 
SAG-M is superior to AS3 in maintaining ATP content and 
inferior to AS3 in avoiding hemolysis.18 In our study, unlike 
in previous investigations, the choice of additive solution 
had a minor impact on hemolysis in our study (Table 4). 
Although it was higher in almost all SAG-M–preserved 
components, a significant difference between SAG-M and 
AS3 was only seen in MCS+–derived RBCs (p < 0.05; Fig. 1). 
Intracellular ATP was better maintained in SAG-M–preserved 
WB and MCS+–derived RBCs (p < 0.05) than in AS3 units 
throughout the entire storage period. ATP values in Cymbal 
RBCs were almost equal for both solutions (Fig. 2). Thus, 
we assume that the differences in hemolysis, ATP content, 
and ATP degradation of deglycerolized and stored RBCs 
cannot be ascribed to the additive solution alone but also to 
the initial production device.20–22 As mentioned earlier, each 
manipulation of RBC units has a negative impact on RBC 
quality, resulting in increased hemolysis and enhanced loss 
of intracellular ATP as a result of increased membrane repair 
processes.1,2,13 Despite all differences observed between the 
RBC manipulation devices and preservation solutions after 
deglycerolization, hemolysis remained less than 0.8 percent in 
all units. The highest hemolysis of 0.34 percent (± 0.09%; Fig. 
1A) was measured in AS3-preserved Cymbal RBCs after 14 
days of storage. In all other units hemolysis remained between 
0.20 percent and 0.30 percent at the end of shelf life (10 days 
for SAG-M–preserved units and 14 days for AS3-preserved 
units; Fig. 1). ATP did not drop below the critical threshold 
of 10 percent of initial values in any of the RBC units.14 These 
observations are in contrast to those in previous investigations 
that described a rise of hemolysis above the threshold of 0.8 
percent in SAG-M–stored deglycerolized RBC units within 1 
week.8 Likewise, hemolysis in AS3-preserved units remained 
less than values described in the literature.23–25 These findings 
may be attributable to the omitted centrifugation step.
Glycerol is known to lead to reduction of ATP and 
2,3-diphosphoglycerate levels in glycerolized RBCs.26 Although 
a repletion of ATP occurs after thawing and deglycerolization, 
a possible negative impact of ATP loss during subzero storage 
cannot be dismissed. However, we were able to show that the 
omission of the third centrifugation step had no negative effect 
on SAG-M– and AS3-preserved units, but rather may allow 
a prolonged storage of deglycerolized RBCs even in SAG-M–
preserved components. This is important for the transfusion 
management of frozen and thawed components and minimizes 
the waste of RBCs.
In summary, all RBC units treated with the new method 
complied with the CE and AABB standards for cryopreserved 
blood components regarding hemolysis and ATP at expiration. 
The RBCs collected conventionally (WB) showed the best 
results irrespective of the additive solution. Thus, we conclude 
that this simplified method is a feasible, time-sparing, and user-
friendly alternative to the established method. Additionally, 
based on the results of this evaluation, the modified procedure 
as well as the medical device equipment has been CE approved 
(Declaration of Conformity of Haemonetics Products 
93/432EG). To what extent the length of subzero storage 
influences the quality of deglycerolized RBCs treated with this 
modified method has yet to be investigated in future studies.
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